GlassScriptPhysician profile
Andrew R Simms
NPI 1700658077
$1,708.52
in general payments reported to CMS, 2019-2025
12 companies · $536 in 2025
The $536 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,173 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502 · Travel and Lodging: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.04 |
| Travel and Lodging | $206.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $720.15 | 2024 | |
| Novo Nordisk INC | $157.38 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $156.65 | 2024 | Arcalyst |
| Amgen INC. | $137.37 | 2024-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.68 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $124.76 | 2025 | |
| Alnylam Pharmaceuticals INC. | $72.96 | 2024-2025 | Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.88 | 2024-2025 | Jardiance |
| Teleflex LLC | $54.61 | 2025 | Guideliner |
| Terumo Medical Corporation | $35.57 | 2025 | Angio-Seal, Metacross Otw |
| Lilly USA, LLC | $32.26 | 2025 | Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $23.25 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Simms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.